2022 Speakers
Take a look at the speakers who joined us in 2022!
Bruce Levine
Barbara and Edward Netter Professor in Cancer Gene Therapy; President, International Society for Cell & Gene Therapy • University of Pennsylvania
Dragan Djordjevic
Associate Director, Cell Therapy Robotics, Data Automation and Machine Learning • Takeda
George Buchman
Vice President, Preclinical Service and Process Development • Catalent Cell and Gene Therapy
Ivan Wall
Director, Advanced Therapies Manufacturing National Training Centre and Co-Founder & Director of FourPlus Immersive • FourPlus Immersive
John Manis
edical Director of Transfusion Medicine at Boston Children, Associated Faculty Kraft Family Blood Donor Center at Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Associate Professor of Pathology Harvard Medical School • Harvard Medical School
John Moscariello
Executive Director, Viral Vector & Gene Editing Process Development • Bristol Myer Squibb
Joseph (Yossi) Schwartz
Medical Director, Transfusion Medicine Quality Assurance • Mount Sinai Health System
Kent Thorup
Regional Vice President of Business Development • QuickSTAT Global Life Science Logistics
Krishendu Roy
Robert A. Milton Chair Professor, Director, NSF ERC on Cell Manufacturing Technologies (CMaT) • Georgia Tech
Louis Walcer
Director, The Kevin M. McGovern Family Center for Venture Development in the Life Sciences • Cornell University
Maria Croyle
Professor of Molecular Pharmaceutics and Drug Delivery/Glaxo Wellcome Professor • University of Texas at Austin
Melissa Sebok
Executive Director – Product, Client & Business Development, Direct Patient Care & Emerging Offerings • American Red Cross
Michael Blackton
Sr. Vice President, Cell Therapy Manufacturing, DeTIL Development • Nurix Therapeutics
Patrick Westmoreland
Principal Scientist, Viral Vector and Gene Editing Process Development • Bristol Myer Squibb
Tara Crnkovich
Senior Director, Site Lead – Clinical Biologics & Cell Therapy Manufacturing • AstraZeneca